small molecule

MOXIFLOXACIN HYDROCHLORIDE

Loss of exclusivity—loss of exclusivity

CompanyApotex →See this company's full patent-cliff portfolio

Drug detail

Brand name	MOXIFLOXACIN HYDROCHLORIDE
Active ingredient	MOXIFLOXACIN HYDROCHLORIDE
Strength	EQ 0.5% BASE
Dosage form	SOLUTION/DROPS
Route	OPHTHALMIC
Modality	Small molecule
FDA approval	June 2017
Marketing status	RX

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.